Family · Pharmaceutical analytical standards
Favipiravir
A broad-spectrum antiviral that inhibits the RNA polymerase of RNA viruses, approved in Japan in 2014 against novel influenza strains and kept as a strategic stockpile in case of a pandemic. This family brings together the active ingredient and other impurities.
Did you know?It is a prodrug: inside the cell it becomes a fake nucleotide that the viral polymerase mistakes for guanosine or adenosine, jamming the copying of the viral genome.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
